m
Tag: 2017 source edit
m (Added embedded dosage calculation)
 
Line 7: Line 7:
| contraindications =  
| contraindications =  
| routes = Intramuscular, Intranasal, Intravenous
| routes = Intramuscular, Intranasal, Intravenous
| dosage = Delayed emergence:
| dosage =  
* 20-200 mcg IV q2-3m
| dosage_calculation = naloxone
Opioid overdose:
* 0.1-2 mg IV/IM/ETT q2-3m
| mechanism = μ-opioid antagonism
| mechanism = μ-opioid antagonism
| adverse_effects = Acute opioid withdrawal, hypotension, arrhythmias, pulmonary edema
| adverse_effects = Acute opioid withdrawal, hypotension, arrhythmias, pulmonary edema

Latest revision as of 00:17, 30 March 2022

Naloxone
Trade names

Narcan

Naloxone.svg
Clinical data
Uses

Reversal of opioid agonism

Routes of administration

Intramuscular, Intranasal, Intravenous

Dosage
Pharmacodynamics
Mechanism of action

μ-opioid antagonism

Adverse effects

Acute opioid withdrawal, hypotension, arrhythmias, pulmonary edema

Pharmacokinetics
Onset of action

1-2 minutes (IV)
2-5 minutes (IM)

Duration of action

30-60 minutes

Metabolism

Hepatic

Elimination half-life

1-1.5 hours

Physical and chemical data
Formula

C19H21NO4

Molar mass

327.380 g/mol

Article quality
Editor rating
In development
User likes
0

Naloxone is an opioid-receptor antagonist which is used for the reversal of opioid overdose.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References